US researchers have demonstrated a new approach to treating snakebites, using nanoparticles to bind to venom toxins and prevent the spread of venom through the body. [ + ]

MTPConnect has awarded $690,000 to three key life sciences projects, in an effort to support researchers, improve collaboration and open up international market opportunities. [ + ]

With the aid of a scanning tunnelling microscope, researchers have employed the diatomic compound as a sensor and transducer to probe and image samples, reportedly gaining an unprecedented amount of information about their structures, bonds and electrical fields. [ + ]

Researchers have uncovered a key factor protecting against age-related DNA damage, providing important clues about how the body guards against cancer. [ + ]

Last week, Arthur Ashkin, Gerard Mourou and Donna Strickland were jointly awarded the Nobel Prize in Physics 2018. [ + ]

A scientist who has developed a system which allows her to video mitochondria inside a cell has been named the winner of the In Memory of Neil Lawrence Prize at the 2018 Centenary Institute Medical Innovation Awards. [ + ]

A new technique is being prepared for clinical application in order to improve breast cancer detection and diagnosis. [ + ]

Removing allergens from milk, making mānuka disease resistant and preventing wilding pines are some potential future uses of gene editing in New Zealand. [ + ]

PhenoMeNal is an online portal that allows researchers and clinicians to analyse large metabolomics datasets. [ + ]

QUE Oncology has launched Phase II trials which will see its novel non-hormonal therapy, for women with breast cancer suffering hot flushes and night sweats, tested at six sites across Australia. [ + ]

The PCOS guideline aims to accelerate the delivery of consistent, evidence-based care across Australia. [ + ]

RMIT University and Atmo Biosciences have signed an agreement that could see an electronic gas-sensing capsule commercially available within four years. [ + ]

Scientists have revealed a better way to identify which ovarian cancer patients should respond to powerful drugs called PARP inhibitors. [ + ]

Stanford scientists have developed an algorithm, called Phrank, that automates the most labour-intensive part of genetic diagnosis. [ + ]

Biotechnology company Immutep has entered into a clinical trial collaboration and supply agreement with Merck and Pfizer. [ + ]